https://cloeformazione.it/blogs/news/obesita-e-farmaci 2026-05-27T17:29:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/Web_1920_3_81e18ab5-4290-42fc-9bb9-a4acff4d89c6.png?v=1779895743 Farmaci per la cura dell'obesità: verità e falsi miti https://cloeformazione.it/blogs/news/food-noise-cosa-neurobiologia-e-terapia 2026-05-27T17:44:13+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/AdobeStock_1946554495_4b9634dd-f269-4a3f-89e6-b2146aca8d98.jpg?v=1779896653 Food noise: neurobiologia e impatto della terapia farmacologica. https://cloeformazione.it/blogs/news/obesita-una-malattia-cronica-progressiva-e-recidivante 2026-05-27T17:50:37+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/Web_1920_14_041ec856-4f85-4bda-9b89-2b0d7ff53ab1.png?v=1779897037 Obesità: una malattia cronica, progressiva e recidivante https://cloeformazione.it/blogs/news/esercizio-fisico-nel-sovrappeso-e-nell-obesita 2026-07-06T09:00:02+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/copertina_89ef355c-0c92-4a36-8a59-3386b66459e6.png?v=1782914677 Esercizio fisico nel sovrappeso e nell’obesità https://cloeformazione.it/blogs/news/glp-1-e-rischio-di-neuropatia-ottica-ischemica-cosa-sappiamo 2026-07-13T10:00:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/ChatGPT_Image_11_lug_2026_13_18_10_96711f88-9415-4758-a917-9ad6a2fbe8ed.png?v=1783864067 GLP-1 e rischio di neuropatia ottica ischemica: cosa sappiamo? https://cloeformazione.it/blogs/news/lobesity-paradox 2026-07-20T16:20:59+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/6270cbe7-600a-4247-b9da-f912cd781312_db98ddc7-1286-4bb9-b324-1f6cf34c1e4c.png?v=1784557259 L'obesity paradox - un paradosso che nasce da un numero sbagliato https://cloeformazione.it/blogs/news/proteine-e-terapia-con-semaglutide-o-tirzepatide-quando-le-whey-possono-essere-utili 2026-08-10T07:00:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/ChatGPT_Image_31_lug_2026_16_00_09_2617ae9f-fed4-4a7e-9da2-ec1ea291cc72.png?v=1785507089 Proteine e terapia con semaglutide o tirzepatide: quando le whey possono essere utili https://cloeformazione.it/blogs/news/amilasi-e-lipasi-quando-ha-senso-dosarle-e-quando-no 2026-08-24T08:00:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/ChatGPT_Image_10_ago_2026_17_18_42_9650da8d-dd2a-4b9f-bdbc-ece49a6b6689.png?v=1786375232 Amilasi e lipasi: quando ha senso dosarle (e quando no) https://cloeformazione.it/blogs/news/obesita-negli-adolescenti-cosa-dicono-le-nuove-linee-guida-italiane 2026-08-30T09:00:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/ChatGPT_Image_25_ago_2026_17_28_59.png?v=1787824111 Obesità negli adolescenti: cosa dicono le nuove linee guida italiane https://cloeformazione.it/blogs/news/pillole-e-dosi-alte-cosa-sta-arrivando-nel-trattamento-dellobesita-e-cosa-dicono-i-numeri 2026-09-13T20:07:31+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/WhatsApp_Image_2026-09-13_at_10.39.26_9b536a4b-91fc-48e5-abb6-a02f51f8953a.jpg?v=1789322851 Pillole e dosi alte: cosa sta arrivando nel trattamento dell'obesità (e cosa dicono i numeri) https://cloeformazione.it/blogs/news/come-scegliere-il-farmaco-giusto-il-nuovo-algoritmo-easo-per-la-terapia-dellobesita 2026-09-20T22:39:06+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/ChatGPT_Image_20_set_2026_22_38_14.png?v=1789936746 Come scegliere il farmaco giusto: il nuovo algoritmo EASO per la terapia dell'obesità https://cloeformazione.it/blogs/news/perche-i-cardiologi-si-occupano-di-obesita 2026-09-28T22:43:51+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/Immagine_ChatGPT_28_set_2026_22_40_14.png?v=1790628231 Perché i cardiologi si occupano di obesità https://cloeformazione.it/blogs/news/obesita-nell-era-dei-nuovi-farmaci-cosa-sappiamo-cosa-no-cosa-ci-aspetta 2026-10-03T16:17:23+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/PHOTO-2026-10-03-15-39-19_d856eeb5-57db-4c27-92da-440cdbbb4d7e.jpg?v=1791037043 Obesità nell’era dei nuovi farmaci: cosa sappiamo, cosa no, cosa ci aspetta https://cloeformazione.it/blogs/news/stesso-bmi-rischio-diverso-cosa-ci-dice-l-obscore-su-chi-trattare-per-primo 2026-10-06T08:00:03+02:00 weekly https://cdn.shopify.com/s/files/1/0995/6769/8262/articles/Screenshot_2026-10-03_alle_16.19.17.png?v=1791037185 Stesso BMI, rischio diverso: cosa ci dice l’OBSCORE su chi trattare per primo